Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-004257-26Phase 4Terminated
Phase 4, randomised trial of metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Organisation name was not entered. Primary endpoints: Change in insulin resistance and Change in quality of life. Started Jan 2005; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-004257-26.